Table 4. Economic costs by laboratory testing at initiation visit (2019 USD).
| POWER study scenario* | MoH scenario** | Scaled-MoH scenario** | ||||
|---|---|---|---|---|---|---|
| Annual cost | Cost per client-month of PrEP | Annual cost | Cost per client-month of PrEP | Annual cost | Cost per client-month of PrEP | |
| CrCl, HBsAg and STI testing | ||||||
| Laboratory and HIV testing (% of total cost) | 31936 (41%) | 20.55 | 10830 (33%) | 6.97 | 59911 (47%) | 9.14 |
| Total cost | 77275 | 49.73 | 32810 | 21.12 | 148245 | 19.39 |
| CrCl and HBsAg testing only | ||||||
| Laboratory and HIV testing (% of total cost) | 2477 (5%) | 1.59 | 2477 (10%) | 1.59 | 13702 (17%) | 2.09 |
| Total cost | 47817 | 30.77 | 24457 | 15.74 | 94333 | 12.34 |
| STI testing only | ||||||
| Laboratory and HIV testing (% of total cost) | 30240 (41%) | 19.46 | 9135 (30%) | 5.88 | 50533 (43%) | 7.71 |
| Total cost | 74392 | 47.88 | 30919 | 19.90 | 137107 | 17.93 |
*Study scenario = costs if paid for by the POWER study
**MoH scenario = costs if paid for by MoH; CrCl = Creatinine clearance; HBsAg = Hepatitis B surface antigen; STI = N. gonorrhoeae and C. trachomatis; MoH = Ministry of Health; PrEP = Pre-exposure prophylaxis.